Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.

ABSTRACT:

Background

To compare the breast cancer-specific survival (BCSS) between patients who underwent tissue or implant reconstruction after mastectomy.

Method

We used the database from Surveillance, Epidemiology, and End Results (SEER) registries and compared the BCSS between patients who underwent tissue and implant reconstruction after mastectomy. Cox-regression models were fitted, adjusting for known clinicopathological features. The interaction between the reconstruction types (tissue/implant) and nodal status (N-stage) was investigated.

Results

A total of 6,426 patients with a median age of 50 years were included. With a median follow up of 100 months, the 10-year cumulative BCSS and non-BCSS were 85.1% and 95.4%, respectively. Patients who underwent tissue reconstruc

SUBMITTER: Ouyang Q 

PROVIDER: S-EPMC4334889 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature